Anuncio
Anuncio
MDCX
Medicus Pharma Ltd. Common Stock
1.63
USDPatrocinado
+0.07
+4.42%
09 ene, 12:56 UTC -5
Apertura
Informes de beneficios de MDCX
Ratio de Sorpresa Positivo
MDCX superó 2 de las últimas 8 estimaciones.
25%
Próximo informe
Fecha del próximo informe
23 mar 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.11
Cambio implícito desde Q3 25 (Revenue/ EPS)
--
/-83.08%
Cambio implícito desde Q4 24 (Revenue/ EPS)
--
/-38.89%
Medicus Pharma Ltd. Common Stock earnings per share and revenue
On 14 nov 2025, MDCX reported earnings of -0.65 USD per share (EPS) for Q3 25, missing the estimate of -0.29 USD, resulting in a -119.74% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.55% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analistas forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an reducir of -83.08% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Preguntas frecuentes
What were Medicus Pharma Ltd. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Medicus Pharma Ltd. Common Stock reported EPS of -$0.65, missing estimates by -119.74%, and revenue of $0.00, 0% as expectations.
How did the market react to Medicus Pharma Ltd. Common Stock's Q3 2025 earnings?
The stock price moved up 4.55%, changed from $2.20 before the earnings release to $2.30 the day after.
When is Medicus Pharma Ltd. Common Stock expected to report next?
The next earning report is scheduled for 23 mar 2026.
What are the forecasts for Medicus Pharma Ltd. Common Stock's next earnings report?
Based on 6
analistas, Medicus Pharma Ltd. Common Stock is expected to report EPS of -$0.11 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio